Know Your Ports - Oncology Nursing News
2017年12月21日 · Throughout the course of treatment, many patients with cancer receive chemotherapy, intravenous fluids, antibiotics, and much more via central venous catheters …
Oncology Nursing News
Panelists discuss how amivantamab’s dual targeting of EGFR and MET may address resistance mechanisms and unmet needs in EGFR-mutated advanced non–small cell lung cancer …
Novel ADC Shows Promise in Platinum-Resistant Ovarian Cancer
2024年11月5日 · SHR-A1921, a novel antibody-drug conjugate (ADC) demonstrated activity and safety for the treatment of patients with platinum-resistant ovarian cancer, according to data …
FDA Approves Zolbetuximab Regimen for Locally Advanced, …
2024年10月18日 · The FDA approved zolbetuximab-clzb (Vyloy) plus fluoropyrimidine- and platinum-containing chemotherapy for the treatment of patients with locally advanced …
PD-L1 CPS Score Could Direct Treatment Decisions in Recurrent ...
2022年4月1日 · PD-L1 combined positive score (CPS) may serve to predict whether a patient with PD-L1–expressing recurrent or metastatic head and neck squamous cell carcinoma (HNSCC) …
ASCO Recommends Abemaciclib for High-Risk HR+, HER2- Breast …
2024年10月24日 · The American Society of Clinical Oncology (ASCO) recently announced guidelines outlining a preference for abemaciclib (Verzenio) over ribociclib (Kisqali) for the …
Letter Warns Clinicians of Severe Infections With Pralsetinib for …
2024年11月4日 · Rigel Pharmaceuticals, the manufacturer of pralsetinib (Gavrelto) wrote a letter to healthcare providers warning about severe and fatal infection risks in patients with lung …
Low-Dose Tamoxifen Shows Continued Efficacy in Adjuvant …
2023年2月17日 · Tamoxifen, at a dose of 5 mg daily (babytam), continued to show a benefit over placebo in reducing the risk of recurrence from invasive breast cancers and ductal carcinoma …
Opinion: The Media May Have Oversold AOH1996, City of Hope's …
2023年9月20日 · Early-phase clinical trials often involve medications that have not yet received their official names. Typically, these innovative drugs are given temporary names made up of …
Adding Chemo to Osimertinib Improves Survival After Progression …
2024年4月5日 · Patients with EGFR-mutated advanced non–small cell lung cancer (NSCLC) treated with firstline osimertinib (Tagrisso) plus platinum-pemetrexed chemotherapy …